Citalid
PrivateLast Round
Series A
Oct 12, 2022
Total Funding Raised
$13.05M
Company Overview
Citalid is a cybersecurity company that provides a SaaS platform for cyber risk quantification, enabling organizations to assess financial exposure and prioritize security investments.
Sector
Cybersecurity
Verticals
Compliance & Risk, InsurTech, Threat Intelligence, Vulnerability Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Citalid Comparables
Compare Citalid with similar companies based on industry and business-model similarity.
Citalid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 12, 2022 | ||||
| Seed | Jun 6, 2019 |
Key People
Founding team and executive leadership
Citalid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNP Paribas Développement | Series A, Seed |
| Seventure Partners | Series A |
| Axeleo Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2025
Grew 16% QoQ, from 44 to 51 employees.
- Nov 26, 2023
Grew 20% QoQ, from 35 to 42 employees.
Citalid Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Citalid's valuation, stock price, and market status.